ARCHIVES

Recurrent Multiple Myeloma Responds To Revimid In Phase II, Side Effects Tolerable

This article is from The Cancer Letter archive.

Vol. 26 No. 1 | January 31, 2003

Download PDF Visit The Full Archive

Related Articles

Science Policy: NI DOD Begins Project For Common Coding Of Cancer Grants

April 2, 1999

The Meeting At the Beverly Hills Suite: Salick, Zeneca Par Way Acrimoniously

May 2, 1997

NCI, SAIC To Support Contracts For Molecular Target Labs.

February 25, 2000

Golde To Step Down At MSK; Porter Joins Hogan & Hartson.

January 26, 2001

NCI Would Add Money For Centers If Number Go Up, Greenwald Says; Five Options For Changes Listed

April 27, 1984

NIH Breaks Ground For Clinical Center

November 14, 1997